Business
Further extension to deadline under Rule 2.6(c)
Spire Healthcare Group plc announced a further extension to the deadline for Toscafund Asset Management LLP to make a firm offer, now set for 5:00 p.m. London time on July 9, 2026. Toscafund, Spire Healthcare's second-largest shareholder, previously proposed a possible cash offer of 250 pence per share, with an option for shareholders to elect for an unlisted rollover equity alternative. Discussions and due diligence are ongoing, and there remains no certainty that a firm offer will be made. Disclaimer*
About this update from Spire Healthcare Group Plc
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE"). IT DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE AND THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADE EVEN IF THE PRE-CONDITIONS ARE SATISFIED OR WAIVED THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR IMMEDIATE RELEASE 25 June 2026 Spire Healthcare Group plc ("Spire Healthcare", the "Company") Further extension to deadline under Rule 2.6(c) of the Code On 14 May 2026, the Company announced that the Company had received a revised non-binding proposal (the "Proposal") from funds advised by Toscafund Asset Management LLP ("Toscafund"), the Company's second largest shareholder, regarding a possible cash offer of 250 pence per Spire Healthcare share for the entire issued and to be issued ordinary share capital of Spire Healthcare (the "Announcement"). The Proposal includes an option for Spire Healthcare shareholders to elect for an unlisted rollover equity alternative in respect of some or all of their Spire Healthcare shares. The Announcement stated that the Proposal is subject to the satisfaction or waiver of a number of customary pre-conditions, including completion of confirmatory due diligence and agreement of definitive transaction documentation. The Announcement also stated that, in accordance with Rule 2.6(a) of the Code, Toscafund was required, by not later than 5.00 p.m. (London time) on 11 June 2026, either to: (i) announce a firm intention to make an offer for the Company in accordance with Rule 2.7 of the Code; or (ii) announce that it does not intend to make an offer for the Company. On 11 June 2026, to allow discussions between the Company and Toscafund to continue to take place and to provide additional time for Toscafund to complete its due diligence and for definitive transaction documentation to be agreed, that deadline was extended with the consent of the Panel on Takeovers and Mergers (the "Takeover Panel"), to 5.00 p.m. (London time) on 25 June 2026 (the "PUSU Deadline"). Discussions between the parties and due diligence remain ongo...
View stock analysis, news, and events for Spire Healthcare Group Plc